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Transcranial magnetic stimulation and
potential cortical and trigeminothalamic
mechanisms in migraine
Anna P. Andreou,1,2, Philip R. Holland,3, Simon Akerman,1,† Oliver Summ,1,z Joe Fredrick4
and Peter J. Goadsby1,3
*These authors contributed equally to this work.
A single pulse of transcranial magnetic stimulation has been shown to be effective for the acute treatment of migraine with and
without aura. Here we aimed to investigate the potential mechanisms of action of transcranial magnetic stimulation, using a trans-
cortical approach, in preclinical migraine models. We tested the susceptibility of cortical spreading depression, the experimental
correlate of migraine aura, and further evaluated the response of spontaneous and evoked trigeminovascular activity of second
order trigemontothalamic and third order thalamocortical neurons in rats. Single pulse transcranial magnetic stimulation signiﬁcantly
inhibited both mechanical and chemically-induced cortical spreading depression when administered immediately post-induction in rats,
but not when administered preinduction, and when controlled by a sham stimulation. Additionally transcranial magnetic stimulation
signiﬁcantly inhibited the spontaneous and evoked ﬁring rate of third order thalamocortical projection neurons, but not second order
neurons in the trigeminocervical complex, suggesting a potential modulatory effect that may underlie its utility in migraine. In
gyrencephalic cat cortices, when administered post-cortical spreading depression, transcranial magnetic stimulation blocked the propa-
gation of cortical spreading depression in two of eight animals. These results are the ﬁrst to demonstrate that cortical spreading
depression can be blocked in vivo using single pulse transcranial magnetic stimulation and further highlight a novel thalamocortical
modulatory capacity that may explain the efﬁcacy of magnetic stimulation in the treatment of migraine with and without aura.
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Migraine is a common neurological disorder (Goadsby
et al., 2002; Lipton et al., 2007) that is the sixth most
common cause of disability worldwide (Global Burden of
Disease Study, 2015). It is characterized by episodic attacks
of headache, nausea, photophobia and phonophobia
(Headache Classiﬁcation Committee of the International
Headache Society, 2013) with 30% of patients having a
transient neurological disturbance: aura (Rasmussen and
Olesen, 1992). While there is a range of treatment options
(Goadsby and Sprenger, 2010), and many interesting devel-
opments (Goadsby, 2015), it is widely accepted that more
and better tolerated therapies are needed.
The pathophysiology of migraine involves the sensory
inputs along the ophthalmic branch of trigeminal nerve,
which projects centrally to second order neurons in the
trigeminocervical complex (TCC) (Goadsby and Hoskin,
1997). These second order neurons give rise to the ascend-
ing trigeminothalamic tract that projects mainly to the ven-
troposteromedial thalamic nucleus (Akerman et al., 2011).
Modulation of the sensory trigeminal inputs both at the
level of the TCC and the thalamus is considered an import-
ant strategy for the management of migraine (Goadsby
et al., 2009). The underlying neurobiology of the migraine
visual aura is considered to be a wave of cortical spreading
depression (CSD), emanating from the occipital lobe, across
the cortex (Lauritzen et al., 2011), with associated cerebral
blood ﬂow changes (Olesen et al., 1990). In experimental
animals this may trigger alterations in neural activity in the
TCC directly (Bolay et al., 2002; Zhang et al., 2011) or via
modulation of key brainstem nuclei (Lambert et al., 2008,
2011).
The medical treatment of migraineurs is challenging as not
all patients respond to available therapies, while side effects
are common (Goadsby and Sprenger, 2010). Recently, con-
siderable progress has been made in the use of neurostimula-
tion approaches, such as occipital nerve stimulation and
hypothalamic deep brain stimulation (Leone et al., 2001), al-
though for both, controlled trials have been disappointing
(Lipton et al., 2009; Fontaine et al., 2010; Saper et al.,
2011; Silberstein et al., 2012), and by their nature the
approaches are invasive. Transcranial magnetic stimulation
(TMS) non-invasively induces weak electrical currents in the
underlying cortex through electromagnetic induction (Barker
et al., 1985). A randomized, double-blind, sham-control clin-
ical trial demonstrated single pulse TMS was effective for the
acute treatment for patients with migraine with aura, with
minimal side effects, and well maintained blinding (Lipton
et al., 2010). The underlying neural mechanism of action,
however, remains to be elucidated. In the current study we
aimed to investigate the effects and potential mechanism of
action of single pulse TMS in migraine using preclinical
models. Some data have been previously presented in a pre-
liminary form (Holland et al., 2009; Andreou et al., 2010b).
Materials and methods
All experiments were conducted under the UK Home Ofﬁce
Animals (Scientiﬁc Procedures) Act 1986, in accordance with
guidelines or with the approval of the University of California
San Francisco, Institutional Animal Care and Use Committee
and the ARRIVE guidelines.
Surgery
Rats
Male Sprague-Dawley rats (n = 80; 270–365 g) were anaesthe-
tized with pentobarbital sodium (60mg/kg, intraperitoneally)
and were prepared for physiological monitoring. The right
femoral vein and artery were cannulated for administration
of supplementary anaesthesia and blood pressure recording,
respectively. When administration of an intravenous test com-
pound was involved, the left femoral vein was additionally
cannulated. The trachea was intubated for ventilation with
oxygen-enriched air (Ugo Basile), before the head of the
animal was ﬁxed in a non-magnetic stereotactic frame (Kopf
Instruments). Core temperature was monitored and maintained
via a homoeothermic blanket (TC-1000, CWE) and the end-
expired pCO2 was continuously monitored and maintained
between 3.5 and 4.5% (Capstar-100, CWE). In the CSD
model, craniotomies were performed to expose the occipital
and frontal cortex for cortical stimulation, steady state cortical
potential and cerebral blood ﬂow recording (Holland et al.,
2012). For recordings in the TCC, a craniotomy was per-
formed to provide access to the middle meningeal artery,
prior to a C1 hemi-laminectomy for exposing the recording
site (Akerman et al., 2013). For recordings from third order
neurons, a craniotomy over the parietal cortex provided access
for the stereotactic positioning of a recording electrode in the
ventroposteromedial thalamic nucleus (Summ et al., 2010). A
second craniotomy was performed to expose the superior sa-
gittal sinus that was electrically stimulated as a means of tri-
geminovascular activation. Where the dural blood vessels were
exposed or the dura mater was incised to expose the cortex
and TCC, the area was covered in warm mineral oil to prevent
dehydration. Anaesthesia was maintained with continuous
intravenous infusion of pentobarbitone (20–30mg/kg/h). A
sufﬁcient depth of anaesthesia was judged from the absence
of nociceptive withdrawal reﬂexes, and no gross ﬂuctuations
in blood pressure. At least 1 h rest was given after surgery and
at the end of each experiment, animals were given a lethal dose
of pentobarbital sodium.
Cats
Male cats (n = 8; 3.65  0.55 kg) were anaesthetized with
-chloralose (60mg/kg intraperitoneally; Sigma) and given
5mg/kg subcutaneous antibiotic (enroﬂoxacin) and local appli-
cation of lidocaine in ear canals. Anaesthesia was maintained
with supplementary doses of -chloralose in 2-hydroxypropyl-
b-cyclodextrin (Research Biochemicals International) given as
an intravenous infusion at a rate of 5–10mg/kg/h (Storer et al.,
1997). During cranial surgery, additional anaesthesia was pro-
vided by isoﬂurane inhalation (0.5–2.5% in oxygen enriched
air). The femoral artery and vein were cannulated (4F; Portex
Ltd.) for continuous monitoring of blood pressure and
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administration of ﬂuids, respectively. Following local anaesthe-
sia with lidocaine hydrochloride the airway was secured with
an endotracheal tube, before the cat was mounted in a non-
magnetic stereotaxic frame (Kopf Instruments). Ocular lubri-
cant was given to prevent corneal dehydration. Core body
temperature (37–39C) was maintained via a homoeothermic
blanket (Harvard Apparatus). Ventilation was maintained
(Ugo Basile) and end-expired pCO2 was continuously moni-
tored and maintained between 3.5 and 4.5% (Capstar-100,
CWE). Arterial blood samples were taken at regular intervals
to ensure that an appropriate acid/base balance was main-
tained. Periodically the depth of anaesthesia was assessed by
testing for the absence of sympathetic, withdrawal and blood
pressure responses to noxious stimuli. Craniotomies were per-
formed via a saline cooled drill, and small dural incisions
allowed access to the occipital and frontal cortex for cortical
stimulation and blood ﬂow measurements. To prevent dehy-
dration, mineral oil was applied at the exposed dura mater. At
least 1 h rest period was given after surgery. At the end of each
experiment animals were euthanized with an intravenous over-
dose of pentobarbital sodium.
Induction and recording of cortical
spreading depression
In rats, cortical steady state potentials (DC-shift) were re-
corded via a glass microelectrode containing 3 M NaCl and
a tip diameter of 1–2 mm. CSD induction was additionally
monitored via laser Doppler (Moor Instruments) recorded
cerebral blood ﬂow changes. The microelectrode was lowered
in the frontal cortex (51mm) via a piezoelectric motor con-
troller, in line with the laser Doppler probe 2mm anterior to
bregma (Fig. 1A). The ﬂuid-ﬁlled pipette was coupled to an
Ag/AgCl pellet and a reference Ag/AgCl electrode placed on
the neck. The signal was fed into an ampliﬁer and a 50–60Hz
noise eliminator (Humbug, Quest Scientiﬁc) and then passed
through an analogue-to-digital converter (CED) and displayed
on a personal computer. CSD in cats was monitored via cere-
bral blood ﬂow changes only, measured via two ﬁbre optic
laser Doppler probes (Moor Instruments); probe 1 was
placed a few millimetres anterior to the CSD induction side
in the occipital cortex. Probe 2 was placed in the ipsilateral
frontal cortex, a few millimetres anterior to bregma (Fig. 1B).
Cerebral blood ﬂow and and DC-shift measurements were re-
corded and analysed using an online analysis system (Spike2
v5.2 software, CED). Following a 1 h rest period CSD induc-
tion was performed by mechanical stimulation of the occipital
cortex 2mm anterior to bregma, via a 26 gauge needle.
Additionally in a separate study in rats, CSD was induced
by local cortical application of potassium chloride (1mg crys-
tal) for 10 s followed by saline washout.
Trigeminovascular stimulation and
extracellular neuronal recordings in
the trigeminocervical complex
In the rat, trigeminovascular activation was achieved by elec-
trical stimulation of the middle meningeal artery using a bipo-
lar stimulating electrode (11–15 V; 0.5Hz; 100-ms duration;
Grass Instruments S88 Stimulator). Extracellular recordings
were made from second order neurons in the TCC (Fig. 1C),
using carbon ﬁbre glass electrodes (impedance 0.8–1.2M;
Kation Scientiﬁc). The signal from the recording electrode
was processed as previously reported and analysed using
spike software (Andreou et al., 2015). Post-stimulation histo-
grams were constructed, as the sum of a total of 20 stimuli, to
record the response of units to electrical stimulation of the
middle meningeal artery as previously described (Holland
et al., 2006). The cutaneous receptive ﬁeld was assessed in
all three dermatomes of the trigeminal innervations as the re-
cording electrode was advanced in the spinal cord. The recep-
tive ﬁeld was assessed for both non-noxious (gentle brushing)
and noxious (pinching, corneal stimulation) inputs. Neurons
were included for further analysis if they responded to noxious
stimulation of the ophthalmic dermatome and demonstrated
convergent inputs from the dura mater. Background cellular
activity was continuously monitored and recorded via peri-
stimulus histograms.
Trigeminovascular stimulation and
extracellular neuronal recordings in
the ventroposteromedial thalamic
nucleus
In the rat, two platinum wire stimulating electrodes were
placed onto the superior sagittal sinus taking care not to
make contact with the cortex (Fig. 1D). Trigeminal afferents
were activated by its stimulating with square-wave pulses using
the lowest possible stimulus intensity to active nociceptive af-
ferents (22–30 V, 100–250 ms, 0.5Hz; Grass Instruments S88
Stimulator). Extracellular recordings were made from neurons
in the ventroposteromedial thalamic nucleus based on the
stereotactic coordinates derived from the atlas of Paxinos
and Watson (1998), using carbon ﬁbre glass electrodes (im-
pedance 0.8–1.2M). The electrode was advanced into the
ventroposteromedial thalamic nucleus in 5-mm steps using a
piezoelectric motor controller until a unit that responded to
trigeminovascular stimulation was identiﬁed. The signal was
then processed and recorded as above. To record the response
of units to electrical stimulation of the superior sagittal sinus,
as a means of trigeminovascular stimulation, post-stimulation
histograms were constructed online, as the sum of a total of 20
stimuli, and saved to disc.
Transcranial magnetic stimulation
We used a bespoke in vivo circular transcranial magnetic
stimulator developed by Neuralieve Inc. for the studies
(Neuralieve, now trading as eNeura Therapeutics). The
device was used as a transcortical stimulator since craniotomy
was required for physiological measurements. The device is
referred to herein by its normal use description as a transcra-
nial magnetic stimulator, although it was applied after crani-
otomy. The stimulator device contains all of the electronics
and operator controls, and is powered from conventional AC
mains voltages. The stimulator consists of two independently-
controlled high-voltage power supplies, each charging separate
energy-storage capacitor banks, which can store up to 277 J
each. The entire device is controlled by a microprocessor. The
capacitor banks are connected to an insulated, remote, Kopf
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Figure 1 Experimental setup and design. (A) Experimental set-up in the rat CSD model. Cortical steady potential (DC-shift) via a Ag/AgCl
glass microelectrode was recorded in addition to cerebral blood flow changes from a single laser Doppler probe, 2 mm anterior to lamda. CSD
was induced at the occipital cortex either mechanically (needle prick) or chemically (KCl). A single pulse TMS (sTMS) coil was positioned 5–7 mm
above the cortex, close to the CSD induction site. (B) Experimental set-up in cat CSD model. CSD was monitored via cerebral blood flow
changes, measured via two laser Doppler probes; probe 1 was placed a few millimetres rostral to the CSD induction side in the occipital cortex.
Probe 2 was placed in the ipsilateral frontal cortex, a few millimetres anterior to the bregma line. A single pulse TMS coil was positioned 5 mm
above the cortex, close to the CSD induction site. (C) Experimental set-up in the trigeminovascular activation model for recordings from the
TCC. Extracellular electrophysiological recordings were performed from second order neurons in the TCC that demonstrated stable activation
in response to trigeminovascular stimulation. A bipolar stimulating electrode onto the middle meningeal artery (MMA) provided square-pulse
electrical stimulation for trigeminovascular activation. A single pulse TMS coil was positioned 5 mm above the occipital cortex. (D) Experimental
set-up in the trigeminovascular activation model for recordings from the ventroposteromedial thalamic nucleus (VPM). Extracellular electro-
physiological recordings were performed from third order neurons in the VPM, following stereotaxic positioning of a recording electrode
(through the parietal cortex). A bipolar stimulating electrode onto the superior sagittal sinus (SSS) provided square-pulse electrical stimulation for
trigeminovascular activation. A single pulse TMS coil was positioned 5–7 mm above the occipital cortex. (E) Bespoke interchangeable Kopf
mountable single pulse TMS coil, kept in an insulated cup of 30 mm diameter. (F) A representative magnetic pulse and pulse characteristics, as
recorded in a data management system and displayed on an oscilloscope, through a pulse detection circuit. (G) A diagram illustrating the
experimental protocol employed in the mechanically induced CSD models (cats and rats). (H) A diagram illustrating the experimental protocol
used for the K + -induced CSD model. (I) A diagram illustrating the experimental protocol used for the trigeminovascular activation models (for
both TCC and VPM recordings). In a group of animals used for trigeminovascular activation and recordings in the VPM, naloxone was used as a
pretreatment to single pulse TMS.
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mountable, circular, magnet-wire coil via a 1.5m long cable.
In response to a trigger, the stored energy in the capacitor
banks is rapidly discharged through the wire coil. The result-
ing high current pulse passes through the coil creating an in-
dividual, transient, monophasic magnetic pulse. In the current
study, two interchangeable coils were tested. The outer diam-
eter of each coil is 20mm and length of 55mm, each kept in
an insulated cup of 30mm diameter for minimizing heat pro-
duced by the coil during TMS (Fig. 1E). The two coils tested
have rise times of 100 and 170ms (Fig. 1F). Pulse intensity is
variable giving a range of stimulation parameters up to 3 T,
measured using a Gaussmeter at 5mm distance from the coil.
The burst width of each single pulse TMS pulse tested in the
current study was kept constant at 360ms. A calibrated pick-
up coil and pulse detection circuit allows the magnetic pulse to
be displayed on an oscilloscope and the pulse characteristics
recorded in a data management system (Fig. 1F). It should be
further noted that although we refer to the stimulation as
transcranial, for methodological purposes the skull immedi-
ately under the coil was removed, the coil was positioned as
if the bone was intact; however, magnetic stimulation did not
need to penetrate the bone and as such may be considered as
direct cortical magnetic stimulation.
Experimental protocol
Transcranial magnetic stimulation in the rat cortical
spreading depression model
The TMS coil was positioned immediately above the occipital
cortical surface, between the induction and laser Doppler re-
cording site. Two control, mechanically-induced CSDs (needle
prick) were initiated to conﬁrm reliable induction and propa-
gation, indicated by cerebral blood ﬂow changes and by a slow
DC potential shift in the presence of a sham single pulse TMS
stimulation (coil placement with no stimulation). The refrac-
tory period between single CSD waves was set at 45min
(Holland et al., 2012). An ipsilateral single pulse TMS pulse
was then triggered 30 s prior to or immediately following
mechanical stimulation of the occipital cortex. In the case of
an inhibited CSD, induction of CSD in the absence of single
pulse TMS was performed 45min later to ensure recovery. In
the case of a non-inhibited CSD, single pulse TMS pulse char-
acteristics/positioning were readjusted and the ability of single
pulse TMS to block CSD was tested 45min later (Fig. 1G). In
a different cohort of animals, the effect of a single active or
sham single pulse TMS pulse 30 s post-stimulation were tested
on the frequency of potassium chloride-induced CSD waves
over 60min (Fig. 1H). Analysis was conducted ofﬂine by in-
dividuals blinded to the experimental grouping.
Transcranial magnetic stimulation in the cat cortical
spreading depression model
The gyrencephalic cat cortex was investigated in a minimum of
animals to investigate further if single pulse TMS can block the
propagation of CSD in that setting. A TMS coil of 170ms rise
time was positioned immediately above the corresponding cor-
tical surface between the two laser Doppler probes. Two con-
trol, mechanically induced CSDs (needle prick) were initiated
in the presence of sham single pulse TMS to conﬁrm reliable
induction and propagation, indicated by cerebral blood ﬂow
changes, with a refractory period between single CSD waves of
60min (Holland et al., 2010). Following induction of CSD and
conﬁrmation of haemodynamic changes in probe 1, a single
pulse TMS pulse was administered to assess its ability to block
the propagation of the CSD wave as recorded by an absence of
a haemodynamic response in probe 2. In the case of an in-
hibited CSD, a CSD in the absence of single pulse TMS was
performed 60min later to ensure recovery. In those trials
where single pulse TMS did not block the propagation of a
CSD, single pulse TMS intensity/positioning was readjusted
and its ability to block the propagation of CSD was tested
60min later (Fig. 1G). No more than ﬁve CSDs were at-
tempted per animal and the longitudinal design precluded
blinding.
Transcranial magnetic stimulation in
the trigeminovascular models
A TMS coil of 170 ms rise time was positioned 5mm above the
occipital cortical surface, ipsilateral to the thalamus or contra-
lateral to the TCC, as appropriate. Spontaneous neuronal
ﬁring was recorded for at least 15min before any intervention.
Post-stimulus histograms, in response to superior sagittal sinus
or middle meningeal artery electrical stimulation, were col-
lected every 5min to ensure stable responses. A single pulse
of TMS (0.55–1.63 T) or sham stimulation was then applied
over the occipital cortex. Post-stimulus histograms were col-
lected every 5min for the ﬁrst 30min post-single pulse TMS,
and every 15min for the following 60min. Spontaneous neur-
onal activity (1-s bins) was recorded continuously for the total
90min post-single pulse TMS application and the neuronal
ﬁring was averaged every 5min for the ﬁrst 30min post-
single pulse TMS and every 15min up to 90min post-single
pulse TMS. To test potential mechanisms of action of single
pulse TMS in a separate cohort of animals that underwent
thalamic recordings, naloxone (5mg/kg, intravenous bolus), a
broad m-opioid receptor antagonist or vehicle was adminis-
tered 5min pre-single pulse TMS or sham single pulse TMS
application and all analyses was conducted ofﬂine by an indi-
vidual blinded to the experimental grouping.
Statistical analysis
Cortical spreading depression
Effects of single pulse TMS on mechanically-induced CSD
were analysed using the Fisher’s exact test due to the binary
nature of CSD as an ‘all or nothing event’ (Graphpad v4). The
effects of single pulse TMS on the total number of CSD’s
initiated as a result of potassium chloride application were
compared by an independent samples t-test (SPSS v20).
Signiﬁcance was assessed at the P5 0.05 level.
Trigeminovascular activation
A repeated measures ANOVA for responses evoked by trige-
minovascular stimulation or of spontaneous activity, for single
pulse TMS effect over time. Bonferroni corrections were
applied and when the assumption of sphericity with regards
to the factor of repeats was violated, adjustments were made
for the degrees of freedom and P-values according to the
Greenhouse–Geisser correction. The results from all cells
were analysed together and when appropriate compared at
different time points by a series of Student’s paired t-tests to
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examine the effect of single pulse TMS over time relative to
baseline. For trigeminovascular evoked activity, as a baseline
response, the average of the three baseline post-stimulus histo-
grams obtained following dural vessel stimulation was used.
Signiﬁcance was assessed at the P5 0.05 level. All data are
expressed as the mean value and the standard error of the
mean for each treatment group.
Results
Single pulse transcranial magnetic
stimulation inhibits cortical spreading
depression
To identify the potential of targeted single pulse TMS in
migraine aura we explored the ability of single pulse TMS
to inhibit CSD the experimental correlate of migraine aura
in a preclinical rat model. CSDs were reliably produced via
cortical mechanical stimulation (needle prick) in all nine
rats studied. Single pulse TMS at sub motor-threshold
intensities commonly induced direct muscle twitches and
showed no baseline effects on cerebral blood ﬂow, DC-
shift or physiological data. Application of a single pulse
TMS (170 ms; 1.11–1.63 T; n = 9) signiﬁcantly inhibited
the number of CSD’s, blocking ﬁve of nine tested
(P50.05; Fig. 2A) with subsequent full recovery following
a 45 min refractory period (Fig. 2B). Additionally applying
the above single pulse TMS parameters 30 s prior to CSD
induction failed to inhibit CSD, blocking only two of eight
(P = 0.47; n = 8). As the stimulation characteristics of the
magnetic pulse, including depth of penetration, rely upon
the rise time and peak energy transferred, we further tested
an alternate TMS coil (100 ms; 1.4 T), which failed to
inhibit the majority of CSD’s, blocking only one of eight
(P = 1.0; n = 8).
To conﬁrm the potential efﬁcacy of single pulse TMS in
CSD we used an alternate method of CSD induction that
relies on potassium chloride induction, we have previously
demonstrated differential pharmacological responses of the
two induction methods suggesting varied mechanisms
(Holland et al., 2012). In agreement with the mechanical
data single pulse TMS (170 ms; 1.3 T) signiﬁcantly
decreased the number of potassium chloride-induced
CSD’s, compared to sham single pulse TMS treated animals
[median and interquartile (IQ) ranges; sham group: n = 8,
median = 3, IQ range 2.75–4; versus single pulse TMS
group: n = 8, median = 1.5, IQ range 1–3; t(14) = 2.59,
P50.05; Fig. 2C–E].
Single pulse transcranial magnetic
stimulation modulates thalamocorti-
cal signalling
To identify a potential thalamic mechanism of single pulse
TMS spontaneous thalamic ventroposteromedial neuronal
responses were recorded in response to single pulse TMS.
Single pulse TMS (170 ms; 1.11–1.63 T) signiﬁcantly in-
hibited baseline spontaneous neuronal activity for
490min (Fig. 3A and B). Additionally dura-sensitive thal-
amic neurons demonstrated signiﬁcantly lower C-ﬁbre-
mediated activity following single pulse TMS (P5 0.05;
Fig. 3D) exceeding 90 min, but not A-ﬁbre mediated ac-
tivity (P = 0.29; Fig. 3C) in response to dural electrical
stimulation. Sham single pulse TMS had no signiﬁcant
impact on spontaneous or evoked thalamic activity over
the entire 90min recording window.
Single pulse transcranial magnetic
stimulation does not modulate trige-
minocervical neurons
Given the observed inhibition of thalamocortical signalling
we investigated if single pulse TMS was inhibiting ascend-
ing trigeminothalamic projections from the TCC. Single
pulse TMS (170 ms, up to 1.63 T; n = 6) failed to inhibit
TCC spontaneous (P4 0.66; Fig. 4A and B) or dural
evoked responses (P40.10; Fig. 4C and D).
Single pulse transcranial magnetic
stimulation acts in part via opioider-
gic mechanisms
To test the pharmacology of the observed single pulse TMS
inhibition of ventroposteromedial thalamocortical signal-
ling in a different experimental group animals were pre-
treated with naloxone (5mg/kg intravenously; n = 7), a
broad spectrum opioid receptor antagonist, single pulse
TMS applied at the same intensity failed to modulate the
spontaneous or evoked neuronal activity of third order
thalamic neurons (P50.29; Fig. 5). Naloxone adminis-
tered alone (n = 5), in the absence of any single pulse
TMS pulse, had no signiﬁcant effect on the ﬁring rate of
third order thalamic neurons compared to a control group
(n = 5) that received saline (P5 0.46).
Single pulse transcranial magnetic
stimulation fails to modulate cortical
spreading depression in the gyrence-
phalic cortex
We have previously demonstrated differential efﬁcacy of
pharmacological targets to block CSD in mesencephalic
versus gyrencephalic cortices (Holland et al., 2010). As
such we explored the efﬁcacy of single pulse TMS against
mechanically induced CSD in the cat cortex following iden-
tiﬁcation of characteristic CBF changes. Single pulse TMS
(170 ms; 1.6–1.8 T) failed to inhibit the majority of
CSD’s, blocking CSD in only two of eight animals
(P = 0.47).
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Here we present data to demonstrate that single pulse TMS
can block both mechanical and chemically-induced CSD.
Furthermore, we show it can modulate trigeminothalamic
mechanisms. The study demonstrates that the modulation
has an opioidergic component. In addition the data suggest
an action at trigeminocervical neurons is unlikely to be the
source of any modulation. Taken together the data provide
plausible mechanisms by which we can begin to understand
the clinical effects of single pulse TMS in migraine.
Migraine aura occurs in 30% of migraineurs
(Rasmussen and Olesen, 1992). The mechanism that under-
lies aura is believed to be CSD, which in animals can be
induced by mechanical, chemical or electrical stimulation of
the cortex (Lauritzen et al., 2011). In our experiments
single pulse TMS was effective in blocking single, mechan-
ically-induced CSD or reducing the frequency of potassium
chloride-induced CSD in rats, when administered soon after
induction. These data suggest this neurostimulation ap-
proach can inﬂuence CSD if applied early post-CSD induc-
tion. Acute pretreatment with single pulse TMS before
mechanical stimulation of the cortex had no effect on pre-
venting induction of CSD using the same stimulating par-
ameters. We have not explored different pulse
characteristics that may have a preventive effect, and the
model offers a plausible way to do this. A number of stu-
dies have shown that repetitive TMS, which is thought to
have longer lasting effects, and not single pulse TMS, can
have treatment effects for various neurological conditions
(Khedr et al., 2005; Wu et al., 2008; Pallanti et al., 2012),
including migraine (Brighina et al., 2004), although none
are absolutely proven. Interestingly, Fregni and colleagues
(2005, 2007) demonstrated that repetitive electrical stimu-
lation of the cortex at 1 and 20Hz increases the frequency
of waves of CSD induced by potassium chloride. These
data, however, may not be directly translated to expected
Figure 2 The impact of TMS on mechanically and chemically induced CSD. (A) Single pulse TMS (sTMS) delivered though a coil with
rise time of 170 ms (1.11–1.63 T) significantly blocked mechanically (needle prick, NP) induced CSDs in five of nine rats when pulsed 30 s post
CSD induction. Single pulse TMS delivered though a coil with rise time of 100 ms, inhibited mechanically induced CSD on the rat cortex in one of
eight rats. (B) Representative example of a CSD blockade by single pulse TMS stimulation. Example demonstrates the successful induction of CSD
pre-single pulse TMS and recovery post-blockade by single pulse TMS. Animals blood pressure recordings were unaffected by single pulse TMS.
(C) Single pulse TMS applied over the rat cortex using a coil of a rise time of 170 ms significantly decreased the frequency of CSD waves, measured
by the number of CBF and intracortical DC-shift changes within 60 min after topical potassium chloride (KCl) application. (D) Representative
example of CSD waves induced by topical KCl application in an untreated animal. (E) Representative example of CSD waves induced by topical
KCl application in an animal treated by single pulse TMS (170 ms, 1.1 T) 30 min post-KCl application. CBF = cerebral blood flow.
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outcomes with repetitive TMS, as in humans high fre-
quency repetitive TMS (20 Hz) is believed to increase
brain excitability, whereas low frequency (1 Hz) decreases
brain excitability (Gangitano et al., 2002; Romero et al.,
2002). Moreover, single pulse TMS deserves consideration
alone since the emerging data are generally indicative of a
useful effect in migraine.
In the rat we identiﬁed that the rise time to peak intensity
of stimulation could be an important component in the
response to single pulse TMS, as the coil of 170ms rise
time was signiﬁcantly more beneﬁcial compared to the
coil of 100ms rise time. Interestingly, the rise time of the
portable single pulse TMS device that has been shown to
produce effective outcomes in migraine with aura patients
(Lipton et al., 2010) is similar (180 ms). Although we
tested a number of different intensities, no single intensity
was found to be more successful, with effective single pulse
TMS pulses ranging between 1.11 and 1.63 T. The depth
of anaesthesia might be a factor for the different intensities
needed, despite every effort to have the least variations be-
tween animals. The output of the human single pulse TMS
devices is below the resting motor threshold or the phos-
phenes threshold for visual cortex stimulation. Optimal
parameters of single pulse TMS, such as the coil size, the
strength of the magnetic ﬁeld generated and duration of
each pulse, have yet to be established for both experimental
animals and migraineurs.
Importantly, single pulse TMS signiﬁcantly modulated
spontaneous and C-ﬁbre evoked trigeminovascular activity
recorded from third order thalamic neurons. Modulation of
nociceptive evoked activity along the ascending trigemi-
nothalamic pathway is considered of pivotal importance
for the treatment of migraine pain. Our data suggest that
such thalamic modulation may explain the efﬁcacy of single
pulse TMS in migraine pain as seen in clinical settings
(Bhola et al., 2015). The thalamus is consistently seen to
Figure 3 The impact of TMS on thalamocoritcal neurons in the ventroposteromedial thalamic nucleus. (A) Representative example
demonstrating the effect of single pulse TMS on spontaneous neuronal activity discriminated from third order neurons recorded in the ventroposter-
omedial thalamic nucleus. A characteristic artefact was recorded during single pulse TMS. (B) Single pulse TMS significantly reduced the spontaneous
neuronal activity recorded from third order neurons in the ventroposteromedial thalamus. (C and D) Single pulse TMS had no significant effect on the
evoked trigeminovascular activity recorded from third order neurons in the ventroposteromedial thalamus in response to A-fibres (C); however, it
significantly inhibited evoked trigeminovascular activity in response to C-fibre activation (D). In the control group (n = 6), in which no single pulse TMS
pulse was delivered, evoked and spontaneous neuronal activity from third order neurons was recorded in the absence of any single pulse TMS application.
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be activated during spontaneous and induced migraine at-
tacks (Afridi and Goadsby, 2006) and it has been addition-
ally shown to be a pivotal area for the development of
sensory hypersensitivity to visual stimuli (Noseda et al.,
2010) and mechanical allodynia (Burstein et al., 2010).
Pharmacological studies of third order neurons in our
model have shown that A- and C-ﬁbres may be affected
by interventions (Andreou et al., 2010a; Andreou and
Goadsby, 2011). In the current study, single pulse TMS,
which modulates third order neurons potentially through
interactions with corticothalamic networks, was found to
inhibit neuronal ﬁring in response to C-ﬁbre activation.
Although it is difﬁcult to dissect out the mechanism of
such neuronal discrimination, it is likely that corticothala-
mic projections affected by single pulse TMS primarily con-
tribute, directly or indirectly, to the modulation of inputs
from the trigeminothalamic pathway generated by activa-
tion of C-ﬁbres peripherally. Of interest, spontaneous
neuronal ﬁring of these thalamic neurons was also in-
hibited, suggesting that the corticothalamic network that
is susceptible to single pulse TMS, further contributes to
the tonic ﬁring of third order neurons. Other potential
mechanisms cannot be excluded however, and this is an
interesting outcome worth further investigation in the
future.
Interestingly, single pulse TMS had no effect over trige-
minovascular activity recorded from second order neurons.
This suggests that the action was due to central top–down
modulation, potentially through cortico-thalamic efferent
connections, without interference with peripheral mechan-
isms, or cortico-spinal efferent modulation. This is further
supported by the fact that single pulse TMS also inﬂuenced
spontaneous thalamic activity. Why single pulse TMS could
modulate cortico-thalamic but not cortico-spinal efferent
networks is unclear. Some possibilities may include the con-
siderably larger efferent connection between the cortex and
Figure 4 The impact of TMS on trigeminothalamic projection neurons in the TCC. (A) Representative example demonstrating the
effect of single pulse TMS (sTMS) on spontaneous neuronal activity discriminated from second order neurons recorded in the TCC. A char-
acteristic artefact was recorded during single pulse TMS. (B) Single pulse TMS applied with a coil of 170 ms rise time at different tesla intensities,
had no significant effect on the spontaneous neuronal activity recorded from second order neurons in the TCC. (C and D) Single pulse TMS
applied with a coil of 170 ms rise time at different tesla intensities, had no significant effect on the evoked trigeminovascular activity recorded from
second order neurons in the TCC, in response to A- (C) and C-fibre (D) Neuronal activity was followed for 90 min post-single pulse TMS;
however, as no significant effect occurred, graphs in B–D report data for the first 45 min post-single pulse TMS.
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the thalamus compared to the dorsal spinal cord, particu-
larly at the occipital cortical area (Arslan, 2001). Of sig-
niﬁcance may also be the fact that most of the single TMS
pulses used in our study were below the motor threshold of
the animal, making it possible that the pulse intensity used
was not sufﬁcient to inﬂuence cortico-spinal efferent.
Measurements of the tesla output of the coil at different
distances suggest it is rather unlikely that the single TMS
pulse reached the thalamic area. It is well-established that
single pulse TMS activates superﬁcial layers of the cortex
and may affect collaterals of cortico-cortical projections
and intercortical interneurons, as well as, cortico-subcor-
tical efferents (Di Lazzaro, 2013). It is worth noting, how-
ever, that CSD may trigger aberrant neural activity in the
TCC of rats (Bolay et al., 2002; Zhang et al., 2011) and
simply blocking CSD would prevent this, suggesting a po-
tential indirect spinal mechanism that we have not tested
currently.
The putative mechanism of action of single pulse TMS
and the molecular changes that may occur post-application
in the cortex or in the thalamic area are not known. It is
likely that single pulse TMS depolarizes cortical neurons in
a way that makes repolarization difﬁcult for some period.
Given that activation is thought to propagate ortho-and
antidromically, the spread of CSD and thus migraine
aura, could be altered. The same may be true for neurons
giving rise to cortico-thalamic efferents. At a molecular
level, mechanically-induced CSD is shown to depend on
sodium channel activation, while potassium chloride-
induced CSD is potassium channel dependent (Akerman
et al., 2008). In our study, single pulse TMS was able to
block both mechanical and potassium chloride induction of
CSD, making it likely that both channel currents may be
implicated in altered membrane polarization following
single pulse TMS. This broader mode of action may be
an additional advantage for single pulse TMS. In our
Figure 5 The impact of opiodergic mechanisms on thalamocortical TMS responses. Pretreatment with naloxone (5 mg/kg; intra-
venous bolus) 5 min pre-single pulse TMS application significantly blocked the inhibitory effects of single pulse TMS over the spontaneous and
evoked firing of third order neurons. Graphs demonstrate the comparison between the single pulse TMS group with and without naloxone pre-
treatment over the spontaneous neuronal activity (A) and trigeminovascular evoked activity in response to A- (B) and C-fibre activation (C). (D)
Naloxone administered alone, in the absence of single pulse TMS, induced no significant changes over spontaneous or evoked trigeminovascular
activity in response to A- and C-fibre activation.
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study we also shed some light onto the molecular mechan-
ism of single pulse TMS inhibition of thalamic trigemino-
vascular responses. Based on previous clinical observations
that demonstrated the involvement of the m-opioid receptor
in analgesia induced with acute repetitive TMS (Taylor
et al., 2012, 2013), we showed that pretreatment with na-
loxone, a broad m-opioid receptor antagonist, could block
the efﬁcacy of single pulse TMS over thalamic activity.
Hence, our study also suggests that the single pulse TMS
mechanism of action in migraine may involve interactions
with the endogenous opioid system, without excluding the
involvement of other systems. The precise level of opioid
blockade by naloxone is unknown. As single pulse TMS
had no effect on the activity of second order neurons, an
interaction with the brainstem opioid system may not be
involved. An interaction with the cortical opioid may
appear more likely. For example, the endogenous opioid
system in the anterior cingulate cortex appears to be of
great importance for the induction of analgesia
(Navratilova et al., 2015); one speculation might be an
interaction of single pulse TMS with this area, through
cortico-cortical connections. More studies are needed to
investigate such a hypothesis and the data do not preclude
involvement of other mechanisms in the effectiveness of
single pulse TMS in migraine treatment.
To investigate if single pulse TMS can block the spread
of a CSD wave across the gyrencephalic cortex, the cat was
used as a model, due to its cortical architecture. Single
pulse TMS was able to block the spread of the travelling
CSD wave across the cortex in only two of eight animals,
an effect that was much lower than that observed in the rat
model. One possibility for this outcome could be that the
size of the coil was suitable for the rat, but not for the cat
cortex. Although in both rats and cats the coil was pos-
itioned just anterior to the induction site at the occipital
cortex and optimal coil orientation has been used (Nakatoh
et al., 1998), a larger cortical area was recruited in rats
compared to cats. The exact cortical area excited in our
experiments is not known, but it should include the occipi-
tal cortex in both rats and cats. Nevertheless, the size of the
coil used in our experiments allowed for a more focal
stimulation, compared to the size of coil used in other
TMS studies in rodents, which varied between 5 and
7 cm (Ji et al., 1998; Yang et al., 2007; Ambriz-Tututi
et al., 2012). Additionally, given the thickness of the
skull, a reduced amount of current may have reached the
underlying cortex in cats compared to rats, whereas the
gyri of the gyrencephalic cortex may have contributed in
the uneven spread of the magnetic ﬁeld. Additionally, dif-
ferent stimulating parameters may have been needed for the
gyrencephalic cat cortex. Interestingly though, previous stu-
dies have shown that compounds that readily block CSD in
rodents are less effective in the cat, despite their clinical
potential (Holland et al., 2010). In addition, cortical
layers are thicker in cat and this may provide other limita-
tions. Taken altogether it is worth observing that human
responses are certainly not 100% and perhaps the cat
results reﬂect the more complex issues attendant stimula-
tion in higher species.
The current study demonstrates a biological rationale for
the use of single pulse TMS for the treatment of migraine
and advances our knowledge of its potential mechanism of
action. The data suggest the most important locus of action
is on thalamic neurons and that some component is opioi-
dergic. Interestingly, one of the traditional sites of action of
anti-migraine treatments, the trigeminocervical complex,
seems less clearly involved. A non-invasive, safe and well-
tolerated new approach to migraine would be welcome by
patients. Offering a plausible biological basis for such a
treatment is an important component of translational
neuroscience that physicians will ﬁnd useful as they con-
sider deploying this therapy.
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